Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Irritable Bowl Syndrome Linked to Chili Pepper Pain Receptor

By Labmedica staff writers
Posted on 18 Jun 2008
Scientists have discovered that people with irritable bowl syndrome (IBS) have higher than usual levels of nerve fibers expressing the transient receptor potential vanilloid 1 (TRPV1), responsible for causing a burning sensation when people eat chili peppers. More...
TRPV1 receptors are also known as capsaicin receptors.

A study, which was published in the June 11, 2008, issue of the journal Gut, suggests that doctors will be able to treat the pain suffered by people with IBS by targeting and blocking the pain receptor. People with severe pain from IBS are currently treated with opiates, which can have serious side effects. Painkillers such as paracetamol and ibuprofen tend to offer little relief. New painkillers to target TRPV1 are currently being developed by pharmaceutic companies and the new findings suggest that such drugs could tackle some of the symptoms of IBS.

Biopsies were studied of colon tissue taken from 23 patients with IBS and from 22 controls, recruited from the gastroenterology clinics and the endoscopy department at Imperial College Healthcare National Health Service (NHS) Trust (London, UK). An estimated one in five UK adults have irritable bowel syndrome (IBS), a painful condition that is poorly understood. Symptoms of IBS include abdominal pain, bloating, and bowel problems such as constipation or diarrhea.
The investigators believe their findings may explain why some people's IBS symptoms worsen after eating spicy food. They also suggest that the presence of more nerve fibers expressing the TRPV1 pain receptors might mean that people with IBS are more susceptible to pain. TRPV1 receptors are also known as capsaicin receptors.


Related Links:
Imperial College Healthcare National Health Service Trust

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.